Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-102 in abdominal contour defects
NCT01712451Phase 2Completed
- Sponsor
- Neothetics
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, fluticasone propionate in Abdominal contour defect, sponsored by Neothetics. Started Aug 2011; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
Abdominal contour defect
Beyond the preview
Go deeper on NCT01712451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712451.